Bond Screener
Insulet
LEI 549300TZTYD2PYN92D43
Organization name
Insulet Corporation
Country name
USA
Country of registration
USA
Industry
Medical Devices
Credit Ratings
in foreign currency
Public debt
45 mln USD
New to Cbonds? · Take a 90-second tour of the platform.
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
Insulet Corporation develops, manufactures, and sells insulin infusion systems for people with insulin-dependent diabetes in the United States. Insulet Corporation was founded in 2000 and is based in Bedford, Massachusetts.
|
General information
-
Organization nameInsulet Corporation
-
Organization statusOperating organization
-
Address600 Technology Park Drive Suite 200 Billerica, USA, 01821
News
IFRS/US GAAP reports
| 2026 | |
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |
Show all
Hide
Authorization required
You need to request access
Stocks
General information
-
Organization nameInsulet Corporation
-
Organization statusOperating organization
-
Address600 Technology Park Drive Suite 200 Billerica, USA, 01821
Codes
-
LEI549300TZTYD2PYN92D43
-
SIC3841 SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
-
NACE*** ***
-
NAICS*** ***
-
CIK0001145197
-
EIN04-3523891
